- Home
- FLGT vs BZAI Comparison
FLGT vs BZAI Comparison
Compare FLGT & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- BZAI
- Stock Information
- Founded
- FLGT 2011
- BZAI 2010
- Country
- FLGT United States
- BZAI United States
- Employees
- FLGT N/A
- BZAI N/A
- Industry
- FLGT Medical Specialities
- BZAI
- Sector
- FLGT Health Care
- BZAI
- Exchange
- FLGT Nasdaq
- BZAI Nasdaq
- Market Cap
- FLGT 584.9M
- BZAI 684.9M
- IPO Year
- FLGT 2016
- BZAI N/A
- Fundamental
- Price
- FLGT $20.31
- BZAI $2.30
- Analyst Decision
- FLGT Buy
- BZAI Buy
- Analyst Count
- FLGT 2
- BZAI 2
- Target Price
- FLGT $24.00
- BZAI $6.50
- AVG Volume (30 Days)
- FLGT 393.7K
- BZAI 302.4K
- Earning Date
- FLGT 05-02-2025
- BZAI 05-14-2025
- Dividend Yield
- FLGT N/A
- BZAI N/A
- EPS Growth
- FLGT N/A
- BZAI N/A
- EPS
- FLGT N/A
- BZAI N/A
- Revenue
- FLGT $292,448,000.00
- BZAI $2,012,000.00
- Revenue This Year
- FLGT $11.79
- BZAI $2,062.29
- Revenue Next Year
- FLGT $10.45
- BZAI $291.44
- P/E Ratio
- FLGT N/A
- BZAI N/A
- Revenue Growth
- FLGT 1.71
- BZAI N/A
- 52 Week Low
- FLGT $14.57
- BZAI $1.70
- 52 Week High
- FLGT $25.11
- BZAI $29.61
- Technical
- Relative Strength Index (RSI)
- FLGT 56.64
- BZAI N/A
- Support Level
- FLGT $20.03
- BZAI N/A
- Resistance Level
- FLGT $21.42
- BZAI N/A
- Average True Range (ATR)
- FLGT 0.82
- BZAI 0.00
- MACD
- FLGT 0.03
- BZAI 0.00
- Stochastic Oscillator
- FLGT 63.06
- BZAI 0.00
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About BZAI Blaize Holdings Inc. Common Stock
Blaize Holdings Inc provides customized,programmable processor architecture suite, artificial intelligence (AI)-enabled edge computing solutions. The company offers semiconductor and software technology company dedicated to revolutionizing the world of AI.